Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

GE boosts Healthymagination drive with Living Independently buy

This article was originally published in Clinica

Executive Summary

As part of its Healthymagination initiative of improving the quality of medical care around the world, GE Healthcare has purchased wireless monitoring specialist Living Independently. For an undisclosed fee, GE will gain the QuietCare passive monitoring system, which is used to wirelessly track the daily patterns of elderly patients’ activities. QuietCare is designed to alert caregivers to behavioural changes that may signal potential health issues or emergency situations, allowing earlier intervention. In September 2008, New York-based Living Independently signed up GE as the global distributor and co-marketer of the QuietCare system (www.clinica.co.uk, October 9 2008). This deal saw GE (Chalfont St Giles, UK) gain a minority ownership stake in Living Independently. GE previously accredited the QuietCare system as a “Healthymagination product” under its scheme to increase access, reduce cost and increase the quality of healthcare delivery.

You may also be interested in...



Alere aided by professional diagnostics sales in fourth quarter

Alere’s professional diagnostics business helped the firm record overall revenue growth in the fourth quarter of 2010, offsetting a fall in influenza-based sales in North America.

Integra and Stout to work on expandable interbody device

Integra LifeSciences has gained exclusive worldwide rights from Stout Medical to develop and commercialise an expandable interbody fusion device.

Gen-Probe eyes portfolio expansion to help boost molecular diagnostics credentials

Gen-Probe recently launched its Panther automated molecular diagnostics system in Europe with the aim of bringing another dimension to its product portfolio. Joseph Harvey met the firm’s CEO, Carl Hull, at the launch of the product in Frankfurt to find how high the firm has set its sights in the molecular diagnostics sector and how it is going to achieve its goals

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT044890

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel